Avastin (Bevacizumab): Side Effects, How it Works, and More - breast cancer bevacizumab


Bevacizumab Improves Survival in Metastatic Breast Cancer breast cancer bevacizumab

Metastatic breast cancer (MBC) is a major cause of death among women worldwide. Progress has been made in treating MBC with the advent of anti- estrogen.

On November 18, , the US Food and Drug Administration (US FDA) announced that breast cancer indication for Avastin (bevacizumab).

Avastin (chemical name: bevacizumab) is a targeted therapy that was approved by the U.S. Food and Drug Administration (FDA) in.